Solvay Pharmaceuticals Announces Strategic Partnership With HUYA To Access New Drug Candidates From China

Brussels – May 18, 2009 — Solvay Pharmaceuticals announces it has signed an agreement with HUYA Bioscience International, a company specialized in enabling and accelerating global co- development of novel biopharmaceutical product opportunities originating in China.

Through this agreement, Solvay Pharmaceuticals will gain access to HUYA’s comprehensive Chinese molecule portfolio, focusing specifically on compounds in the cardiovascular area.